Rate of Adverse Effects of Medium- to High-Dose Glucocorticoid Therapy in Systemic Lupus Erythematosus: A Systematic Review of Randomized Control Trials
- 29 March 2017
- journal article
- research article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 37 (6) , 519-524
Abstract
The efficacy of glucocorticoids (GCs) in treating systemic lupus erythematosus (SLE) is beyond doubt. However, GCs-related adverse effects (AEs) are multiple and serious. Despite the current available evidence suggesting to reduce daily doses of prednisone <7.5 mg/day, or even to withdraw it, in the real-life practice, it is not uncommon to see patients receiving medium doses (up to 30 mg/day prednisone or equivalent) or high doses (≥30 mg/day).Keywords
This publication has 17 references indexed in Scilit:
- A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment—Clinical response compared to literature and immunological re-assessmentAutoimmunity Reviews, 2015
- Glucocorticoid use and abuse in SLERheumatology, 2012
- Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic reviewAnnals of the Rheumatic Diseases, 2010
- Steroid‐sparing effects of methotrexate in systemic lupus erythematosus: A double‐blind, randomized, placebo‐controlled trialArthritis Care & Research, 2008
- Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosusAnnals of the Rheumatic Diseases, 2005
- Glucocorticoids in the treatment of rheumatic diseases: An update on the mechanisms of actionArthritis & Rheumatism, 2004
- Accrual of organ damage over time in patients with systemic lupus erythematosus.2003
- Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritisThe Lancet, 1992
- A double blind controlled trial of methylprednisolone infusions in systemic lupus erythematosus using individualised outcome assessment.Annals of the Rheumatic Diseases, 1987
- Azathioprine plus Prednisone Compared with Prednisone Alone in the Treatment of Systemic Lupus ErythematosusAnnals of Internal Medicine, 1975